Pharmion deal gets OK from proxy firms
Rocky Mountain News
Published February 27, 2008 at 12:05 a.m.
Text size 
Pharmion, based in Boulder, says that all four major proxy-advisory services have recommended shareholders vote in favor of its merger with Celgene.
"We are pleased that ISS, as well as the other leading independent proxy advisory firms - Glass Lewis & Co., PROXY Governance and Egan-Jones Proxy Services - have all recognized the strategic and economic logic of our merger with Celgene," said Patrick Mahaffy, Pharmion's president and chief executive officer.
The deal comes to a vote March 6.
Featured
-
DNC in Denver
Complete coverage of the 2008 Democratic National Convention.
-
The Crevasse
A five-part series that examines one tragic day on Mount Rainier.
-
Deadly denial
Sick nuclear workers applied for government compensation but most haven't seen a dime.
-
Final Salute
The Rocky followed Maj. Steve Beck as he took on the most difficult duty of his career.
-
'Colorado's burning'
Coverage of the state's worst wildfires.
-
Columbine shootings
Coverage of the April 20, 1999, shootings at Littleton's Columbine High School.
-
The Crossing
Colorado's deadliest traffic accident killed 20 children on Dec. 14, 1961.
-
Osveli's journey
Osveli Sales left Guatemala for a better life. Two months later, he came home in a box.
-
Wake for an Indian warrior
Oglala Sioux bestow a tribute to the first tribal fatality in Iraq.
